“Assessing Oxime Reactivation Efficacy Using Principal Component Analysis: Insights from Nerve Agents Inhibited Human Butyrylcholinesterase: Original Scientific  Article”. 2026. ADMET and DMPK 14 (May). https://doi.org/10.5599/admet.3361.